Patents Assigned to Indoco Remedies Limited
  • Patent number: 10508128
    Abstract: The present invention DISCLOSES a novel process for preparing sodium glucose transporters 2 (SGLT2) inhibitor compounds of Formula IX.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: December 17, 2019
    Assignee: Indoco Remedies Limited
    Inventors: Ranjeet Nair, Palangat Vayalileveetil Ramesan, Sandip Kacharu Deshmukh, Aditi Milind Panandikar
  • Patent number: 9649319
    Abstract: The present invention relates to a process for manufacturing sterile Brinzolamide Ophthalmic Suspension. Specifically, the present invention relates to a process for manufacturing sterile ophthalmic suspension comprising Brinzolamide sterilized by Dry Heat Sterilization and pharmaceutical suspension obtained by using the said sterilized Brinzolamide. The present invention also relates to a process of manufacturing sterile ophthalmic suspension comprising combination of Brinzolamide sterilized by Dry Heat Sterilization and beta blocker.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: May 16, 2017
    Assignee: INDOCO REMEDIES LIMITED
    Inventors: Aditi Panandikar, Sundeep Bambolkar, Kavita Inamdar, Sapna Ramesh, Pradnya Bagde
  • Patent number: 9492459
    Abstract: The present invention relates to a novel pharmaceutical composition of Linezolid. The present invention relates to a novel pharmaceutical composition comprising Linezolid Form III along with pharmaceutically acceptable excipients and a process to prepare the said composition. The present invention relates to an oral dosage forms for the treatment of severe infections caused by Gram-positive bacteria.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: November 15, 2016
    Assignee: Indoco Remedies Limited
    Inventors: Aditi Panandikar, Sundeep Bambolkar, Kavita Inamdar, Sapna Ramesh, Amol Burkul, Nasir Shaikh
  • Publication number: 20150250796
    Abstract: The present invention relates to a process for manufacturing sterile Brinzolamide Ophthalmic Suspension. Specifically, the present invention relates to a process for manufacturing sterile ophthalmic suspension comprising Brinzolamide sterilized by Dry Heat Sterilization and pharmaceutical suspension obtained by using the said sterilized Brinzolamide. The present invention also relates to a process of manufacturing sterile ophthalmic suspension comprising combination of Brinzolamide sterilized by Dry Heat Sterilization and beta blocker.
    Type: Application
    Filed: October 8, 2013
    Publication date: September 10, 2015
    Applicant: INDOCO REMEDIES LIMITED
    Inventors: Aditi Panandikar, Sundeep Bambolkar, Kavita Inamdar, Sapna Ramesh, Pradnya Bagde
  • Patent number: 8957252
    Abstract: The present invention discloses novel process for the preparation of (2R)-2-acetamido-N- benzyl-3-methoxypropanamide of Formula I involving novel intermediates of Formula-XIX and Formula-XX.
    Type: Grant
    Filed: July 26, 2011
    Date of Patent: February 17, 2015
    Assignee: Indoco Remedies Limited
    Inventors: Mangesh Narayan Rajadhyaksha, Ranjeet Nair, Nilesh Balkrishna Shrigadi, Aditi Milind Panandikar
  • Patent number: 8853456
    Abstract: Disclosed herein is an improved process for the preparation of 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol of Formula-I and its pharmaceutically acceptable salt which comprises the reaction of (S)-1-(dimethylamino)-2-methylpentan-3-one of formula VIII with 3-bromo anisole of formula II under Grignard conditions to get the compound (2S,3R)-1-(dimethylamino)-3-(3-methoxyphenyl)-2-methyl pentan-3-ol of formula V followed by activation of the —OH group of the formula V to convert into sulfonate esters of formula IX, which are on reductive deoxygenation to yield (2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentan-1-amine of formula VII and demethylation of formula VII to obtain the compound 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol of Formula-1.
    Type: Grant
    Filed: August 16, 2011
    Date of Patent: October 7, 2014
    Assignee: Indoco Remedies Limited
    Inventors: Mangesh Narayan Rajadhyaksha, Ranjeet Nair, Sandip Kacharu Deshmukh, Somnath Ambadas Khabale, Aditi Milind Panandikar
  • Publication number: 20130137890
    Abstract: Disclosed herein is an improved process for the preparation of 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol of Formula-I and its pharmaceutically acceptable salt which comprises the reaction of (S)-1-(dimethylamino)-2-methylpentan-3-one of formula VIII with 3-bromo anisole of formula II under Grignard conditions to get the compound (2S, 3R)-1-(dimethylamino)-3-(3-methoxyphenyl)-2-methyl pentan-3-ol of formula V followed by activation of the —OH group of the formula V to convert into sulfonate esters of formula IX, which are on reductive deoxygenation to yield (2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentan-1-amine of formula VII and demethylation of formula VII to obtain the compound 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol of Formula-1.
    Type: Application
    Filed: August 16, 2011
    Publication date: May 30, 2013
    Applicant: Indoco Remedies Limited
    Inventors: Mangesh Narayan Rajadhyaksha, Ranjeet Nair, Sandip Kacharu Deshmukh, Somnath Ambadas Khabale, Aditi Milind Panandikar